Cigna Investments’s Omnicell OMCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
– Sell
-1,386
Closed -$206K – 706
2021
Q3
$206K Hold
1,386
– – 0.02% 703
2021
Q2
$210K Buy
+1,386
New +$193K 0.02% 705
2020
Q2
– Sell
-6,329
Closed -$415K – 784
2020
Q1
$415K Hold
6,329
– – 0.05% 368
2019
Q4
$515K Buy
6,329
+678
+12% +$52K 0.05% 382
2019
Q3
$397K Hold
5,651
– – 0.04% 457
2019
Q2
$425K Buy
5,651
+35
+0.6% +$2.84K 0.05% 430
2019
Q1
$455K Sell
5,616
-1,611
-22% -$121K 0.05% 410
2018
Q4
$441K Buy
+7,227
New +$489K 0.04% 372

Other funds holding OMCL

Cigna Investments's OMCL Position: Q4 2021 in Review

Cigna Investments sold out of Omnicell (OMCL) in Q4 2021, closing a stake of 1,386 shares — an estimated $206K sold.

Cigna Investments first reported a position in OMCL in Q4 2018 and held it in 8 quarters. The position peaked at $515K in Q4 2019. 421 funds tracked by Wall St. Rank hold OMCL as of Q4 2021.

  • Cigna Investments reported no remaining Omnicell position as of Q4 2021 after selling out during the quarter.
  • Cigna Investments sold 1,386 Omnicell shares in Q4 2021, an estimated $206K.
  • Cigna Investments first reported a position in Omnicell in Q4 2018 and held it in 8 quarters.
  • Cigna Investments's Omnicell position peaked at $515K in Q4 2019.
  • 421 funds tracked by Wall St. Rank held Omnicell as of Q4 2021.

Based on Cigna Investments's 13F filing for Q4 2021, filed 14 Feb 2022.